Front Cell Infect Microbiol 12:1065235 Zhang SJ, Zhang YF, Bai XH, Zhou MQ, Zhang ZY, Zhang SX, Cao ZJ, Wang L, Ding SW, Zheng HJ, Liu YN, Yu GY, Liu WJ (2024b) Integrated network pharmacology analysis and experimental validation to elucidate the mechanism of acteoside in treating diabetic kidney disease
Teichman and colleagues, for example, documented prolonged and amplified GH and IGF-1 secretion using a long-acting GHRH analog, illustrating how the GHRH side of the equation can be optimized
[5] [6] La evidencia de ensayos como LEADER (liraglutida) y REWIND (dulaglutida) sugiere que los beneficios cardiovasculares y renales de estos medicamentos persisten mientras se mantiene el tratamiento, aunque estos beneficios varan segn el agente especfico
doi: 10.1155/2021/6685204
& Tabtiang, R
Depositions are one of the most important parts of a lawsuit against drug manufacturers, like Eli Lilly or Novo Nordisk